Coherus BioSciences
CHRS
#8754
Rank
โ‚ฌ0.19 B
Marketcap
1,24ย โ‚ฌ
Share price
-1.40%
Change (1 day)
42.72%
Change (1 year)

Operating Margin for Coherus BioSciences (CHRS)

Operating Margin as of July 2026 (TTM): -349.00%

According to Coherus BioSciences 's latest financial reports and stock price the company's current Operating Margin is -349.00%. At the end of 2025 the company had an Operating Margin of -434.23%.

Operating Margin history for Coherus BioSciences from 2014 to 2026

Operating Margin at the end of each year

Year Operating Margin Change
2025-434.23%-46.8%
2024-816.23%781.22%
2023-92.62%-33%
2022-138.24%57.24%
2021-87.92%-408.27%
202028.52%9.46%
201926.06%
2017-15,314.01%22682.15%
2016-67.22%-90.98%
2015-745.44%165.98%
2014-280.26%-85.63%
2013-1,949.65%12.13%
2012-1,738.70%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Amgen
AMGN
24.41%-106.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
8.45%-102.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-84.50%-75.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.